Insider Transactions in Q1 2025 at Clear Point Neuro, Inc. (CLPT)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 12
2025
|
Mazin Sabra Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,627
-11.46%
|
$86,151
$13.18 P/Share
|
Mar 12
2025
|
Mazin Sabra Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,050
+18.41%
|
-
|
Mar 12
2025
|
L. Jeremy Stigall Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,545
-6.94%
|
$72,085
$13.18 P/Share
|
Mar 12
2025
|
L. Jeremy Stigall Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,497
+16.25%
|
-
|
Mar 12
2025
|
Danilo D'Alessandro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,284
-10.48%
|
$107,692
$13.18 P/Share
|
Mar 12
2025
|
Danilo D'Alessandro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,313
+17.11%
|
-
|
Mar 12
2025
|
Joseph Michael Burnett CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,405
-7.46%
|
$304,265
$13.18 P/Share
|
Mar 12
2025
|
Joseph Michael Burnett CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
42,414
+11.92%
|
-
|
Mar 11
2025
|
Danilo D'Alessandro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,106
-3.25%
|
$25,272
$12.7 P/Share
|
Mar 11
2025
|
Danilo D'Alessandro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,146
+6.01%
|
-
|
Mar 11
2025
|
L. Jeremy Stigall Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,967
-4.41%
|
$35,604
$12.7 P/Share
|
Mar 11
2025
|
L. Jeremy Stigall Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,292
+10.97%
|
-
|
Mar 06
2025
|
Mazin Sabra Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,022
-13.56%
|
$91,286
$13.19 P/Share
|
Mar 06
2025
|
Mazin Sabra Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,827
+21.07%
|
-
|
Mar 06
2025
|
L. Jeremy Stigall Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,361
-9.73%
|
$82,693
$13.19 P/Share
|
Mar 06
2025
|
L. Jeremy Stigall Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,777
+21.37%
|
-
|
Mar 06
2025
|
Joseph Michael Burnett CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
26,160
-8.8%
|
$340,080
$13.19 P/Share
|
Mar 06
2025
|
Joseph Michael Burnett CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
47,407
+13.75%
|
-
|
Mar 06
2025
|
Danilo D'Alessandro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,529
-13.57%
|
$123,877
$13.19 P/Share
|
Mar 06
2025
|
Danilo D'Alessandro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,765
+21.09%
|
-
|
Feb 22
2025
|
L. Jeremy Stigall Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.87%
|
$14,528
$16.72 P/Share
|
Jan 02
2025
|
Timothy T. Richards |
BUY
Grant, award, or other acquisition
|
Direct |
725
+1.1%
|
$10,875
$15.38 P/Share
|
Jan 02
2025
|
Linda M. Liau |
BUY
Grant, award, or other acquisition
|
Direct |
193
+0.61%
|
$2,895
$15.38 P/Share
|
Jan 02
2025
|
Pascal E R Girin |
BUY
Grant, award, or other acquisition
|
Direct |
406
+0.54%
|
$6,090
$15.38 P/Share
|
Jan 02
2025
|
R John Fletcher |
BUY
Grant, award, or other acquisition
|
Direct |
375
+0.4%
|
$5,625
$15.38 P/Share
|